Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2025 ∙ Lamichhane, A. Sharma, S. Gautam, P. Gaire, S. Acharya, S.

Efficacy, immunogenicity, and safety of typhoid conjugate vaccines in children and adolescents: a systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Typhoid
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Bardach, A. Berrueta, M. Ciapponi, A. Sambade, J. M. Castellana, N. Ballivian, J. Brizuela, M. Caravario, J. Comande, D. Couto, E. Mazzoni, A. Ortega, V. Parker, E. P. K. Salva, F. Stegelmann, K. Schieffelin, J. S. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P.

Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates

  • Adults
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Reiter, L. Voracek, M. Betsch, C. Bohm, R.

Emphasising herd immunity in vaccine advocacy: a systematic review and meta-analysis

  • All age groups
  • Parents/caregivers
  • Healthcare workers
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Wang, Y. Zhang, Y. Wang, J. Shi, N. Jin, H.

Enhancing influenza vaccination uptake: a systematic review and meta-analysis of intervention strategies

  • All age groups
  • Pregnant women
  • Healthcare workers
  • Influenza
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Agrawal, R. Rehman, T. Sinha, D. Chakraborty, P. Sakthivel, M. Kumar, D. Mitra, S. Karumathil, A. Kanungo, S. Pati, S.

Epidemiological trends and determinants of mumps outbreaks: a systematic review and meta-analysis

  • All age groups
  • Mumps
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Wu, P. C. Huang, I. H. Wang, C. W. Chung, W. H. Chen, C. B.

Erythema Multiforme and Epidermal Necrolysis Following COVID-19 Vaccines: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Pan, Y. Jia, Z. Zhang, Y. Wu, Y. Jiang, J.

Estimates of the global prevalence of occult hepatitis B virus infection in population under 18 years old: a systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Hepatitis B
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Liu, J. Zhang, Y. Zhang, H. Tan, H.

Estimating the effects of interventions on increasing vaccination: systematic review and meta-analysis

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Szondy, I. Lorincz, K. Walter, A. Mohammed, A. A. Hegyi, P. Kiss, N. Meznerics, F. A. Banvolgyi, A.

Evaluating cross-protection: Meningococcal vaccines show effectiveness in gonorrhoea prevention - A systematic review and meta-analysis

  • All age groups
  • Meningococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Jotautis, V. Sarantaki, A.

Evaluating the Efficacy and Safety of Hepatitis E Vaccination in Reproductive-Age Women: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Hepatitis E
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...